Menu
Back to Journals » Biologics: Targets and Therapy » Volume 12
Review
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 29,965 | Dovepress* | 12,065+ | 1,825 | 13,890 | |
| PubMed Central* | 17,900 | 1,296 | 19,196 | ||
| Totals | 29,965 | 3,121 | 33,086 | ||
| *Since 18 January 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar